RI
TEVA icon

Ridgewood Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Ridgewood Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,000
Closed -$1K – 195
2022
Q2 		$1K Hold
15,000
– – ﹤0.01% 186
2022
Q1 		$5K Hold
15,000
– – ﹤0.01% 193
2021
Q4 		$5K Hold
15,000
– – ﹤0.01% 197
2021
Q3 		$11K Buy
15,000
+5,000
+50% +$46.8K 0.01% 191
2021
Q2 		$10K Buy
+10,000
New +$106K 0.01% 193

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Ridgewood Investments's TEVA Position: Q3 2023 in Review

Ridgewood Investments sold out of Teva Pharmaceuticals (TEVA) in Q3 2023, closing a stake of 1,500 shares — an estimated $11.3K sold.

Ridgewood Investments first reported a position in TEVA in Q4 2016 and held it in 8 quarters. The position peaked at $294K in Q2 2017. 435 funds tracked by Wall St. Rank hold TEVA as of Q3 2023.

  • Ridgewood Investments reported no remaining Teva Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Ridgewood Investments sold 1,500 Teva Pharmaceuticals shares in Q3 2023, an estimated $11.3K.
  • Ridgewood Investments first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 8 quarters.
  • Ridgewood Investments's Teva Pharmaceuticals position peaked at $294K in Q2 2017.
  • 435 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2023.

Based on Ridgewood Investments's 13F filing for Q3 2023, filed 20 Oct 2023.